Photodynamic therapy in combination with immune checkpoint inhibitors plus chemotherapy for first-line treatment in advanced or metastatic gastric or gastroesophageal junction cancer: A phase 2–3 clinical trial protocol

Introduction: The immune checkpoint inhibitor (ICI) has been approved as the first-line therapy for metastatic gastric cancer in China. The treatment response of immune checkpoint inhibitor is highly dependent on the immune condition within the tumor microenvironment. Photodynamic therapy (PDT) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yang, Yu, Rong, Wang, Na, Bai, Yuping, Shi, Qianling, Maswikiti, Ewetse Paul, Chen, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908746/
https://www.ncbi.nlm.nih.gov/pubmed/36778024
http://dx.doi.org/10.3389/fphar.2023.1063775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908746/
https://www.ncbi.nlm.nih.gov/pubmed/36778024
http://dx.doi.org/10.3389/fphar.2023.1063775

Ejemplares similares